Jupiter Neurosciences (JUNS) Non Operating Interest Expenses (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Non Operating Interest Expenses for 4 consecutive years, with $90618.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 7883.96% year-over-year to $90618.0 in Q2 2026; TTM through Jun 2026 was $155409.0, a 10.78% increase from a year earlier, with the FY2025 full-year figure at $66020.0, down 73.42% from the prior year.
• Non Operating Interest Expenses was $90618.0 for Q2 2026 at Jupiter Neurosciences, up from $62463.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $107382.0 in Q3 2024 and troughed at $1135.0 in Q2 2025.
• A 4-year average of $50509.5 and a median of $58383.0 in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses plunged 98.89% in 2025 and jumped 7883.96% in 2026, its largest moves.
• Over 4 years, Non Operating Interest Expenses stood at $58383.0 in 2023, then tumbled by 47.68% to $30545.0 in 2024, then soared by 104.5% to $62463.0 in 2025, then jumped by 45.07% to $90618.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $90618.0 (Q2 2026), $62463.0 (Q4 2025), and $1193.0 (Q3 2025), per Business Quant data.